A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia
Creators
- 1. Cancer Unit, Disease Control Division, Ministry of Health, 62590 Putrajaya, Malaysia
- 2. Clinical Research Center, Sultanah Bahiyah Hospital, 05460 Alor Setar, Kedah, Malaysia
- 3. Department of Medicine, Sultanah Bahiyah Hospital, 05460 Alor Setar, Kedah, Malaysia
Description
Introduction The immunochemical fecal occult blood test (iFOBT) has been widely used for opportunistic colorectal cancer (CRC) screening in average-risk individuals seeking care from public health clinics in Malaysia. This study provides a 5-year outcome evaluation of such a practice.
Methods The findings for a few outcome indicators, ranging from the iFOBT uptake to the CRC and polyp detection rates, were generated from the data contributed by 583 public health clinics between 2014 and 2018. The trends in their changes were also evaluated.
Results The iFOBT uptake constantly increased over the years (p < 0.001), totaling 2.29 % (n = 127,957) as at 2018. Nearly 10 % (n = 11,872) of the individuals screened had a positive test result. Of those who underwent colonoscopy (n = 6,491), 4.04 % (n = 262) and 13.93 % (n = 904) were found to have CRC and polyps, respectively.
Conclusion An uptrend in the CRC screening uptake was witnessed following the introduction of the iFOBT in public health clinics.
Files
03 47. CE 2020 - iFOBT nationwide.pdf
Files
(1.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:8730e8b37d904c2d87c0924149de7a4c
|
1.6 MB | Preview Download |